[DGRh S2e guidelines : Diagnostic and treatment of adult-onset Still's disease (AOSD)]
- PMID: 36367577
- DOI: 10.1007/s00393-022-01276-4
[DGRh S2e guidelines : Diagnostic and treatment of adult-onset Still's disease (AOSD)]
References
Literatur
-
- Abid N, Bin Kahlid A (2009) Adult onset Stills disease in a tertiary care hospital of Pakistan. J Pak Med Assoc 59;7:464–467
-
- Aeberli D, Oertle S, Mauron H et al (2002) Inhibition of the TNF-pathway: use of infliximab and etanercept as remission-inducing agents in cases of therapy-resistant chronic inflammatory disorders. Swiss Med Wkly 132:414–422
-
- Aggarwal R, Ringold S, Khanna D et al (2015) Distinctions between diagnostic and classification criteria? Arthritis Care Res 67:891–897. https://doi.org/10.1002/acr.22583 - DOI
-
- Ahn SS, Yoo B‑W, Jung SM et al (2017) Application of the 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome in patients with adult-onset still disease. J Rheumatol 44:996–1003. https://doi.org/10.3899/jrheum.161286 - DOI
-
- Aikawa NE, de Medeiros Ribeiro AC, Saad CGS et al (2011) Is anti-TNF switching in refractory Still’s disease safe and effective? Clin Rheumatol 30:1129–1134. https://doi.org/10.1007/s10067-011-1735-0 - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources